Robert D Inman, BA, MD

Ankylosing Spondylitis is an autoimmune arthritis which is the most common form of inflammatory joint disease affecting the spine. The Spondylitis Program at Toronto Western Hospital plays a leading role in defining the genetic basis of this disease, developing new outcome measures and introducing innovative new biologic agents for the treatment of this disease.

Reactive Arthritis is a form of arthritis that is triggered by an infection. We are studying epidemic outbreaks across Canada to learn how genetic and environmental factors contribute to autoimmunity.

Immunology of Infection holds the promise of defining the genetic control of defence against bacterial infections. These translational studies incorporate clinical research, experimental models of arthritis and basic cellular and molecular immunology.
Arthritis Care Res (Hoboken). 2019 Nov 01;:
Sari I, Lee S, Tomlinson G, Johnson SR, Inman RD, Haroon N
Arthritis Rheumatol. 2019 Oct 10;:
Gracey E, Yao Y, Qaiyum Z, Lim M, Tang M, Inman RD
Rheumatology (Oxford). 2019 Oct 08;:
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD
Rheumatol Ther. 2019 Jun 28;:
Mease P, Walsh JA, Baraliakos X, Inman R, de Vlam K, Wei JC, Hunter T, Gallo G, Sandoval D, Zhao F, Dong Y, Bolce R, Marzo-Ortega H
Sensors (Basel). 2019 Jun 13;19(12):
Nowicki SA, Inman RD, Esque TC, Nussear KE, Edwards CS
J Rheumatol. 2019 May 01;:
Passalent L, Hawke C, Lawson D, Omar A, Alnaqbi K, Wallis D, Steinhart H, Silverberg M, Wolman S, Derzko-Dzulynsky L, Haroon N, Inman RD



Professor, Department of Immunology, University of Toronto
Deputy Physician in Chief Research, University Health Network
Director, Spondylitis Program, University Health Network